CPHI Pharma Awards open to global innovators, scientists, entrepreneurs and social leaders

CPHI Barcelona 2023The 20th anniversary edition of the CPHI Pharma Awards is now open for entries, with three new categories created to reflect the surge of innovation sweeping the industry - from new methodologies to sustainability and philanthropic initiatives.

In the last year, pharma has continued its rapid rate of innovation embracing the speed of pandemic R&D, but added to this are new social goals that aim to improve the wider world as well as bottom lines and therapeutic/device options.

In total, the CPHI Pharma Awards will celebrate global leaders from across 12 categories, including returning categories spanning development and manufacturing of devices and drugs, alongside packaging, supply chain, sustainability, regulatory compliance, and the much-vaunted CEO of the Year award. Previous winners include a who’s who of pharma manufacturing CEOs from Piramal and WuXi AppTec to Catalent and last year’s winner Aragen Life Sciences.

A new Start-up award has been specifically introduced to honour exhibitors from the start-up zone - a new part of CPHI Barcelona that celebrates the raft of recent stellar start-ups [only exhibitors here may enter]. In this new era of global collaborative research, many of the biggest innovations emerge from some of the smallest companies and this category will span projects at proof-of-concept stage to protype or commercial launch.

In a change from 2022 and to reflect the wider efforts of many companies, the Covid Response category is renamed the Accelerating Innovation award. The winner will be selected based on innovations used to help combat the impact of global healthcare emergencies or future health emergencies.

Finally, the new Heart of Pharma award will celebrate the acceleration of social, ethical and philanthropic activities. This is to recognise the individuals, companies or initiatives that have made the most significant contributions to improving patient engagement or centricity, promoted corporate social responsibility and/or improvements to healthcare accessibility and equity.

"One of the things we enjoy most at CPHI is celebrating the outstanding achievements of the industry in not just improving methods, processes and supply-side efficiencies but the real-world impacts these have on delivery and in improving patient outcomes and experiences. Pharma has always been an industry centred on innovation and this has accelerated post pandemic, and we see new developments coming from all sizes of companies and parts of the world. These are the leaders we will celebrate at the awards, and we look forward to reviewing entries submitted by the industry’s best and brightest. Our eponymous awards are your chance to be recognised among your peers at pharma's largest global event," added Tara Dougal, content director, Pharma at Informa.

To submit your entry, please visit the CPHI Pharma Awards website with entries closing on 15th May 2023:
https://www.cphi.com/europe/en/pharma-awards-2023.html

CPHI Pharma Awards 2023 Categories

  • Accelerating Innovation
  • API Development & Innovation
  • Finished Formulation
  • Manufacturing Excellence
  • Drug Delivery & Device Innovation
  • Packaging & Machinery
  • Supply Chain Excellence
  • Sustainability
  • Regulatory and Compliance
  • CEO of the Year
  • Start-Up Initiative
  • At the Heart of Pharma

About Informa Markets

Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world’s leading exhibitions organizer, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year.

For more information, please visit www.informamarkets.com.

CPHI Japan (19-21 April, 2023 at the Big Sight Exhibition Centre - Tokyo, Japan); CPHI North America (25-27 April, 2023 at Pennsylvania Convention Center, United States), CPHI China (19-21 June 2023 at SNIEC - Shanghai, China)CPHI South East Asia (12-14 Jul 2023 at QSNCC, Bangkok, Thailand); CPHI Barcelona (24-26 October 2023 at Fira Barcelona, Barcelona), CPHI & PMEC India (28-30 November 2023 at the India Expo Mart, Greater Noida, Delhi NCR - Delhi, India); Pharmapack Europe (24-25 Jan, 2023 at Paris Expo, Porte de Versailles - Hall 7.2, Paris).

Most Popular Now

AstraZeneca enters license agreement with KYM Bios…

AstraZeneca and KYM Biosciences Inc.* have entered into a global exclusive licence agreement for CMG901, a potential first-in-class antibody drug conjugate (ADC) targetin...

Pfizer's elranatamab receives FDA and EMA filing a…

Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review for the company's Biologics License Application (BLA) ...

Pfizer receives positive FDA Advisory Committee vo…

Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that avail...

US FDA Advisory Committee votes to support effecti…

GSK plc (LSE/NYSE: GSK) announced that the US Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that the avail...

"Semantic similarity" leads to novel dru…

The words that researchers use to describe their results can be harnessed to discover potential new treatments for Parkinson's disease, according to a new study published...

Tumour cells' response to chemotherapy is driven b…

Cancer cells have an innate randomness in their ability to respond to chemotherapy, which is another tool in their arsenal of resisting treatment, new research led by the...

First nasal monoclonal antibody treatment for COVI…

A pilot trial by investigators from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, tested the nasal administration of the ...

Nanosatellite shows the way to RNA medicine of the…

The RNA molecule is commonly recognized as messenger between DNA and protein, but it can also be folded into intricate molecular machines. An example of a naturally occur...

Gene and cell therapies to combat pancreatic cance…

Pancreatic cancer is an incurable form of cancer, and gene therapies are currently in clinical testing to treat this deadly disease. A comprehensive review of the gene an...

Engineered bacteria find tumors, then alert the au…

Combining discoveries in cancer immunology with sophisticated genetic engineering, Columbia University researchers have created a sort of "bacterial suicide squad" that ...

Digital twin opens way to effective treatment of i…

Inflammatory diseases like rheumatoid arthritis have complex disease mechanisms that can differ from patient to patient with the same diagnosis. This means that currently...

AI conjures proteins that speed up chemical reacti…

For the first time, scientists have used machine learning to create brand-new enzymes, which are proteins that accelerate chemical reactions. This is an important step in...